SECOND OPINION: BIG PHARMA ONCE AGAIN TRIES TO DEFEND THE PATENT ABUSE STATUS QUO
Oct 23, 2024
Eli Lilly Opinion Column Reiterates Debunked Arguments on Innovation as Brand… Read More
© 2025 CSRXP- All Rights Reserved
Second Opinion
SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”
Jun 26, 2024
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
SECOND OPINION: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS ARE THE ROOT CAUSE OF HIGH DRUG PRICES
Jun 17, 2024
Breaking Down the Facts on Drug Prices, Innovation, Patent Abuse… Read More
SECOND OPINION: BIG PHARMA’S OUT-OF-POCKET PLANS ON BRAND NAME INHALERS MAY BE DESIGNED TO FURTHER UNDERMINE COMPETITION
Apr 8, 2024
Big Pharma’s Announcements Designed to Deflect from Criticism and Scrutiny… Read More
SECOND OPINION: THE RELATIONSHIP BETWEEN BIG PHARMA’S PRICE-GOUGING AND BLOCKBUSTER SPENDING ON DIRECT-TO-CONSUMER ADVERTISING
Dec 8, 2023
Greater List Price Transparency Will Help Deter Big Pharma’s Egregious… Read More
SECOND OPINION: NUMBER OF CANCER DRUGS IN DEVELOPMENT CLIMBS DESPITE PHRMA CLAIM DRUG PRICING SOLUTIONS WOULD UNDERMINE ONCOLOGY INNOVATION
Nov 10, 2023
PhRMA Undercuts Own Rhetoric by Showing the Cancer Drug Pipeline is Growing… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Sep 19, 2023
Brand Name Drug Companies Claim Lowering Rx Prices Will Undercut R&D —… Read More
SECOND OPINION: BIG PHARMA EXEC BOOED AS HE DISMISSES AFFORDABILITY CONCERNS ON HIGH PRICED TREATMENTS AS “LUDICROUS”
Dec 9, 2022
Regeneron Co-Founder Says, “Forget About That” When Pressed on How… Read More
SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC
Sep 1, 2022
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More
SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS
Aug 5, 2022
Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High… Read More
SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION
Jul 11, 2022
PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t… Read More
SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN
Jun 17, 2022
Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade… Read More